Multifunctional peptide-assembled micelles for simultaneously reducing amyloid-β and reactive oxygen species

Lei, Li and Zou, Zhifeng and Liu, Jin and Xu, Zhiai and Fu, Ying and Tian, Yang and Zhang, Wen (2021) Multifunctional peptide-assembled micelles for simultaneously reducing amyloid-β and reactive oxygen species. Chemical Science, 12 (18). pp. 6449-6457. ISSN 2041-6520 (https://doi.org/10.1039/d1sc00153a)

[thumbnail of Lei-etal-CS-2021-Multifunctional-peptide-assembled-micelles-for-simultaneously-reducing-amyloid-β]
Preview
Text. Filename: Lei_etal_CS_2021_Multifunctional_peptide_assembled_micelles_for_simultaneously_reducing_amyloid_.pdf
Final Published Version
License: Creative Commons Attribution 4.0 logo

Download (4MB)| Preview

Abstract

The excessive production and deposition of amyloid-β (Aβ) is one of the most important etiologies of Alzheimer's disease (AD). The interaction between Aβ and metal ions produces aberrant reactive oxygen species (ROS), which induce oxidative stress and accelerate the progression of AD. To reduce Aβ plaques and ROS to maintain their homeostasis is an emerging and ingenious strategy for effective treatment of AD. Herein, we report the rational design of multifunctional micelles (MPGLT) based on a polymer-grafted peptide to simultaneously clear Aβ and ROS for AD therapy. The MPGLT integrating three functional peptides as a ROS scavenger (tk-GSH), β-sheet breaker (LP) and an autophagy activator (TK) respectively, could capture and degrade Aβ. Meanwhile, the tk-GSH on the surface of MPGLT effectively scavenges the intracellular ROS. Consequently, MPGLT reduced the cytotoxicity of Aβ and ROS. In vivo animal studies using an AD mouse model further showed that MPGLT could transport across the blood–brain barrier for decreasing the Aβ plaque and eliminating ROS in vivo. This peptide micelle-based synergistic strategy may provide novel insight for AD therapy.